Price movement over the last 24 hours
Asahimas Flat Glass Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Asahimas Flat Glass Tbk trades at Rp3,160 (market cap 1.33T, 800 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 160.57B, 2.51M 24h volume). The key difference: Asahimas Flat Glass Tbk is far larger — about 8.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (2.51M versus 800). Which is the better fit depends on your goals.
| AMFG | OBAT | |
|---|---|---|
Market Cap | 1.33T | 160.57B |
Volume | 800 | 2.51M |
Lot | 8 | 25.09K |
Turnover | 2.52M | 636.74M |
Average Price | 3,155 | 253.78 |
Value | 2.52M | 636.74M |
Indicative Equilibrium Price | — | 242 |
Indicative Equilibrium Volume | — | 146 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Asahimas Flat Glass Tbk (The Company) was established within the foreign capital investment framework of Law No. 1 of 1967 and Law No. 11 of 1970, by deed of notary public Koerniatini Karim dated 7 October 1971 No. 4, as amended by deed of the same notary dated 6 January 1972 No. 9; these deeds were approved by the Minister of Justice under No. J.A.5/5/19 dated 17 January 1972. The Company is a joint venture between Asahi Glass of Japan and the Rodamas Group of Indonesia. Asahi Glass is one of the leading glass producers in the world.
Read more on AMFG →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →